| scholarly article | Q13442814 |
| P2093 | author name string | E Rivas | |
| O Nieto | |||
| J A Fontenla | |||
| M L de Ceballos | |||
| P2860 | cites work | Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients | Q64891702 |
| Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon: a double-blind, placebo-controlled, multicenter trial | Q64955113 | ||
| Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease. | Q67219131 | ||
| Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease | Q67935479 | ||
| Reduction of circulating 3-O-methyldopa by inhibition of catechol-O-methyltransferase with OR-611 and OR-462 in cynomolgus monkeys: implications for the treatment of Parkinson's disease | Q68003971 | ||
| Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione | Q70764166 | ||
| Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2- nitrophenyl)vinyl]phenyl ketone | Q71694577 | ||
| Ro 40-7592: inhibition of COMT in rat brain and extracerebral tissues | Q28328872 | ||
| Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease | Q28334363 | ||
| Catechol-O-methyl transferase: pharmacological aspects and physiological role | Q34059894 | ||
| Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. | Q34168866 | ||
| Catecholamine metabolism: basic aspects and clinical significance. | Q34194962 | ||
| Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease. | Q37941603 | ||
| Decarboxylase inhibitors | Q40511832 | ||
| Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors | Q42196980 | ||
| Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III. | Q42540259 | ||
| Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly | Q42547131 | ||
| Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat | Q42711918 | ||
| Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase | Q44307365 | ||
| Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase | Q48234347 | ||
| Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone | Q48438194 | ||
| Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat. | Q48647573 | ||
| 3-o-methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway | Q48912011 | ||
| Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral Inhibitor | Q51107835 | ||
| 3-Methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease | Q51680487 | ||
| 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease | Q53835278 | ||
| Transamination is a Major Pathway of L-Dopa Metabolism following Peripheral Decarboxylase Inhibition | Q59081547 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1667-1673 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | In vivo effects of new inhibitors of catechol-O-methyl transferase | |
| P478 | volume | 126 |
| Q45387108 | Antitumor and scavenging radicals activities of some polyphenols related to dehydroabietylamine derivatives |
| Q36745779 | Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration |
| Q48478225 | Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. |
| Q44437032 | Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. |
Search more.